cancer panel
Realm IDx Cancer Genome Profiling Test Gets National Health Coverage in Japan
The company said it will launch the test, which combines DNA and RNA analysis, for research use only in markets outside of Japan.
Illumina, Pillar Biosciences Ink Global Distribution Agreement for Cancer Dx Assays
The firms said their distribution deal will facilitate the integration of Pillar's precision oncology assays and Illumina's sequencers.
Thermo Fisher Scientific's IonTorrent Genexus platform can provide cancer panel results in about a day, but data on clinical impact of the fast turnaround has not yet been produced.
Illumina, Myriad Genetics Expand Partnership to Bring TSO 500 HRD Assay to US
The firms are creating a CDx alliance to help pursue HRD regulatory approvals for both the MyChoice HRD assay and a future clinical IVD test from Illumina.
Everything Genetic, Berkshire and Surrey Pathology Services Jointly Launch Cancer NGS Service in UK
BSPS will provide cancer sequencing services using two cancer gene panels currently under development at Everything Genetic to customers across the UK.